09
April
2018
|
15:37
Europe/Amsterdam

‘Chemobrain’ the new enemy in cancer fight

Assoc Prof Alexandre Chan from the Dept of Pharmacy at NUS Faculty of Science led a study of 131 breast cancer survivors which has found that three in 10 of the people studied complained of cognitive issues up to a year after chemotherapy had ended.